85 related articles for article (PubMed ID: 1837350)
1. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
Mitra G
Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
3. The trk family of oncogenes and neurotrophin receptors.
Lamballe F; Klein R; Barbacid M
Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
[TBL] [Abstract][Full Text] [Related]
4. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
5. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
Rodrigues GA; Park M
Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
[TBL] [Abstract][Full Text] [Related]
6. The trk oncogene abrogates growth factor requirements and transforms hematopoietic cells.
Katzav S; Martin-Zanca D; Barbacid M; Hedge AM; Isfort R; Ihle JN
Oncogene; 1989 Sep; 4(9):1129-35. PubMed ID: 2674855
[TBL] [Abstract][Full Text] [Related]
7. The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines.
Helin K; Velu T; Martin P; Vass WC; Allevato G; Lowy DR; Beguinot L
Oncogene; 1991 May; 6(5):825-32. PubMed ID: 1646987
[TBL] [Abstract][Full Text] [Related]
8. Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor).
Longati P; Bardelli A; Ponzetto C; Naldini L; Comoglio PM
Oncogene; 1994 Jan; 9(1):49-57. PubMed ID: 8302603
[TBL] [Abstract][Full Text] [Related]
9. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
10. Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.
Greco A; Fusetti L; Miranda C; Villa R; Zanotti S; Pagliardini S; Pierotti MA
Oncogene; 1998 Feb; 16(6):809-16. PubMed ID: 9488046
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding.
Fukasawa K; Zhou R; Matten WT; Armstrong AJ; Daar I; Oskarsson M; Sathyanarayana BK; Maclvor L; Wood TG; Vande Woude GF
Oncogene; 1995 Oct; 11(8):1447-57. PubMed ID: 7478569
[TBL] [Abstract][Full Text] [Related]
12. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors.
Tapley P; Lamballe F; Barbacid M
Oncogene; 1992 Feb; 7(2):371-81. PubMed ID: 1312698
[TBL] [Abstract][Full Text] [Related]
13. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.
Mitra G; Martin-Zanca D; Barbacid M
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6707-11. PubMed ID: 3477801
[TBL] [Abstract][Full Text] [Related]
14. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
Roccato E; Pagliardini S; Cleris L; Canevari S; Formelli F; Pierotti MA; Greco A
Oncogene; 2003 Feb; 22(6):807-18. PubMed ID: 12584559
[TBL] [Abstract][Full Text] [Related]
15. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.
Martin-Zanca D; Hughes SH; Barbacid M
Nature; 1986 Feb 27-Mar 5; 319(6056):743-8. PubMed ID: 2869410
[TBL] [Abstract][Full Text] [Related]
16. Replacement of the conserved tyrosine 1210 by phenylalanine in the insulin receptor affects insulin-induced dephosphorylation of focal adhesion kinase but leaves other responses intact.
Van der Zon GC; Ouwens DM; Dorrestijn J; Maassen JA
Biochemistry; 1996 Aug; 35(32):10377-82. PubMed ID: 8756693
[TBL] [Abstract][Full Text] [Related]
17. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
18. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
[TBL] [Abstract][Full Text] [Related]
19. C127 cells resistant to transformation by tyrosine protein kinase oncogenes.
Cuadrado A; Talbot N; Barbacid M
Cell Growth Differ; 1990 Jan; 1(1):9-15. PubMed ID: 2150330
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
Eager KB
Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
